Journal
BRITISH JOURNAL OF CANCER
Volume 124, Issue 4, Pages 817-830Publisher
SPRINGERNATURE
DOI: 10.1038/s41416-020-01167-y
Keywords
-
Categories
Funding
- FORMA Therapeutics
- Pfizer Inc.
- EPSRC [EP/N034295/1]
- Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS), China [2018-I2M-2-002]
- EPSRC [EP/N034295/1] Funding Source: UKRI
- MRC [MC_U137884181, MR/K012037/1] Funding Source: UKRI
Ask authors/readers for more resources
This study has identified novel ISGylation targets in chronic myeloid leukaemia (CML)-derived cell line, shedding light on the potential of USP18 as a cancer target for regulating antigenicity and radiosensitivity. The findings suggest that USP18 plays a crucial role in modulating immune responses and sensitivity to treatment in cancer cells.
Background Interferon (IFN) signalling pathways, a key element of the innate immune response, contribute to resistance to conventional chemotherapy, radiotherapy, and immunotherapy, and are often deregulated in cancer. The deubiquitylating enzyme USP18 is a major negative regulator of the IFN signalling cascade and is the predominant human protease that cleaves ISG15, a ubiquitin-like protein tightly regulated in the context of innate immunity, from its modified substrate proteins in vivo. Methods In this study, using advanced proteomic techniques, we have significantly expanded the USP18-dependent ISGylome and proteome in a chronic myeloid leukaemia (CML)-derived cell line. USP18-dependent effects were explored further in CML and colorectal carcinoma cellular models. Results Novel ISGylation targets were characterised that modulate the sensing of innate ligands, antigen presentation and secretion of cytokines. Consequently, CML USP18-deficient cells are more antigenic, driving increased activation of cytotoxic T lymphocytes (CTLs) and are more susceptible to irradiation. Conclusions Our results provide strong evidence for USP18 in regulating antigenicity and radiosensitivity, highlighting its potential as a cancer target.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available